Dbv Technologies S.A. Sponsored ADR logo

Dbv Technologies S.A. Sponsored ADR (DBVT)

Market Closed
16 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM)
$
9. 05
-0.06
-0.6586%
$
234.43M Market Cap
- P/E Ratio
- Div Yield
592,900 Volume
-0.66 Eps
$ 9.11
Previous Close
Add Transaction
Day Range
8.63 9.13
Year Range
8.63 26.18
Want to track DBVT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Strength Seen in DBV Technologies (DBVT): Can Its 6.8% Jump Turn into More Strength?

Strength Seen in DBV Technologies (DBVT): Can Its 6.8% Jump Turn into More Strength?

DBV Technologies (DBVT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Zacks | 1 year ago
Are You Looking for a Top Momentum Pick? Why DBV Technologies S.A.

Are You Looking for a Top Momentum Pick? Why DBV Technologies S.A.

Does DBV Technologies S.A. (DBVT) have what it takes to be a top stock pick for momentum investors?

Zacks | 1 year ago
DBV Technologies (DBVT) Is a Great Choice for 'Trend' Investors, Here's Why

DBV Technologies (DBVT) Is a Great Choice for 'Trend' Investors, Here's Why

DBV Technologies (DBVT) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

Zacks | 1 year ago
Here's Why Momentum in DBV Technologies (DBVT) Should Keep going

Here's Why Momentum in DBV Technologies (DBVT) Should Keep going

DBV Technologies (DBVT) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

Zacks | 1 year ago
DBV Technologies ADRs Rise After Up to $306.9M in New Financing

DBV Technologies ADRs Rise After Up to $306.9M in New Financing

American depositary receipts of DBV Technologies gained after the company reported new financing of up to $306.9 million.

Marketwatch | 1 year ago
DBV Aligns With FDA On Accelerated Approval For Viaskin Peanut Patch In Younger Kids

DBV Aligns With FDA On Accelerated Approval For Viaskin Peanut Patch In Younger Kids

On Wednesday, DBV Technologies SA DBVT reached a significant milestone with the FDA regarding its Viaskin Peanut patch for toddlers aged 1–3 years.

Benzinga | 1 year ago
DBV Technologies S.A. (DBVT) Q2 2024 Earnings Call Transcript

DBV Technologies S.A. (DBVT) Q2 2024 Earnings Call Transcript

DBV Technologies S.A. (NASDAQ:DBVT ) Q2 2024 Earnings Conference Call July 30, 2024 5:30 PM ET Company Participants Katie Matthews – Investor Relations Daniel Tassé – Chief Executive Officer Pharis Mohideen – Chief Medical Officer Virginie Boucinha – Chief Financial Officer Conference Call Participants Jon Wolleben – Citizens JMP Operator Welcome to the DBV Second Quarter Financial Results and Business Update Conference Call.

Seekingalpha | 2 years ago